Literature DB >> 12297045

Hop is an unusual homeobox gene that modulates cardiac development.

Fabian Chen1, Hyun Kook, Rita Milewski, Aaron D Gitler, Min Min Lu, Jun Li, Ronniel Nazarian, Robert Schnepp, Kuangyu Jen, Christine Biben, Greg Runke, Joel P Mackay, Jiri Novotny, Robert J Schwartz, Richard P Harvey, Mary C Mullins, Jonathan A Epstein.   

Abstract

Hop is a small, divergent homeodomain protein that lacks certain conserved residues required for DNA binding. Hop gene expression initiates early in cardiogenesis and continues in cardiomyocytes throughout embryonic and postnatal development. Genetic and biochemical data indicate that Hop functions directly downstream of Nkx2-5. Inactivation of Hop in mice by homologous recombination results in a partially penetrant embryonic lethal phenotype with severe developmental cardiac defects involving the myocardium. Inhibition of Hop activity in zebrafish embryos likewise disrupts cardiac development and results in severely impaired cardiac function. Hop physically interacts with serum response factor (SRF) and inhibits activation of SRF-dependent transcription by inhibiting SRF binding to DNA. Hop encodes an unusual homeodomain protein that modulates SRF-dependent cardiac-specific gene expression and cardiac development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297045     DOI: 10.1016/s0092-8674(02)00932-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  100 in total

1.  Interconversion between intestinal stem cell populations in distinct niches.

Authors:  Norifumi Takeda; Rajan Jain; Matthew R LeBoeuf; Qiaohong Wang; Min Min Lu; Jonathan A Epstein
Journal:  Science       Date:  2011-11-10       Impact factor: 47.728

Review 2.  Stem cells and the formation of the myocardium in the vertebrate embryo.

Authors:  Leonard M Eisenberg; Steven W Kubalak; Carol A Eisenberg
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2004-01

3.  Combination of a zinc finger and homeodomain required for protein-interaction.

Authors:  Gregory E Smith; Douglas S Darling
Journal:  Mol Biol Rep       Date:  2003-12       Impact factor: 2.316

4.  Type I MADS-box genes have experienced faster birth-and-death evolution than type II MADS-box genes in angiosperms.

Authors:  Jongmin Nam; Joonyul Kim; Shinyoung Lee; Gynheung An; Hong Ma; Masatoshi Nei
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

Review 5.  Cell cycle regulation to repair the infarcted myocardium.

Authors:  Joshua D Dowell; Loren J Field; Kishore B S Pasumarthi
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 6.  Cardiovascular genomics: a current overview of in vivo and in vitro studies.

Authors:  Devi Mariappan; Johannes Winkler; Jürgen Hescheler; Agapios Sachinidis
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 7.  Re-employment of developmental transcription factors in adult heart disease.

Authors:  Toru Oka; Jian Xu; Jeffery D Molkentin
Journal:  Semin Cell Dev Biol       Date:  2006-11-24       Impact factor: 7.727

8.  Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation.

Authors:  Ryota Terada; Sonisha Warren; Jonathan T Lu; Kenneth R Chien; Andy Wessels; Hideko Kasahara
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

9.  Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.

Authors:  Hyun Kook; John J Lepore; Aaron D Gitler; Min Min Lu; Wendy Wing-Man Yung; Joel Mackay; Rong Zhou; Victor Ferrari; Peter Gruber; Jonathan A Epstein
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  HATs off to Hop: recruitment of a class I histone deacetylase incriminates a novel transcriptional pathway that opposes cardiac hypertrophy.

Authors:  Yasuo Hamamori; Michael D Schneider
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.